Transforming Telehealth Services
ARCpoint Inc. (TSXV: ARC) is making significant progress in enhancing telehealth services with its innovative platform, MyARCpointLabs. This technology allows healthcare practitioners to effortlessly order diagnostic tests, overcoming hurdles that are typically faced in remote healthcare settings. This recent development comes as an upgrade to the Application Programming Interface (API) created in collaboration with MD Care Group.
Improving Access to Diagnostic Testing
This integration empowers physicians to easily place orders for diagnostic tests at various ARCpoint-affiliated physical locations, addressing a major challenge for telehealth professionals. According to CEO John Constantine, laboratory test results are vital for more than 70% of medical decisions, as reported by the US Centers for Disease Control and Prevention. Unfortunately, many telehealth providers have struggled with direct access to diagnostic testing services, which has resulted in lower follow-up rates for tests ordered during virtual consultations.
The Role of Diagnostic Testing
To illustrate, studies show that when diagnostic tests are ordered during telehealth consultations, the completion rates are significantly lower compared to in-person visits. By enabling telehealth doctors to quickly order these tests, ARCpoint seeks to enhance the availability of essential information for patient care and treatment planning.
Strategic Collaborations to Enhance Services
Teaming up with MD Care Group, a leader in affordable virtual healthcare, represents a significant milestone for ARCpoint. This partnership helps consumers connect with board-certified healthcare providers to discuss their diagnostic test results, which enhances the effectiveness of telehealth by filling gaps in communication and patient care.
The Creation of CRESSO Brands
In another forward-thinking move, ARCpoint has partnered with Any Lab Test Now (ALTN) to establish the joint venture known as CRESSO Brands. With over 360 locations across the nation, this franchise network is now the largest of its kind in the US, offering direct access to a variety of laboratory testing services—including phlebotomy and specimen collection.
Establishing a Comprehensive Healthcare Ecosystem
Mr. Constantine highlighted that this new functionality strengthens the connectivity among healthcare providers. By promoting collaboration within the healthcare ecosystem, ARCpoint encourages greater engagement from service providers, leading to a more thorough and efficient healthcare landscape. The aim is to ensure that the telehealth model not only flourishes but also improves the quality of care available to patients.
A Vision for Enhanced Telehealth
This groundbreaking solution aligns with ARCpoint's mission to empower both healthcare providers and patients, making the overall healthcare experience more accessible and efficient. With these advancements, ARCpoint is committed to leveraging technology to foster proactive and preventive health measures, ultimately leaving a positive mark on the industry.
Frequently Asked Questions
What is ARCpoint's new service offering?
ARCpoint has launched a feature that allows telehealth practitioners to order diagnostic tests directly via their platform, improving patient care and access to testing services.
How does the new integration work?
The integration utilizes an API created by MD Care Group, linking telehealth providers with ARCpoint's diagnostic testing locations.
How does this affect patient care?
By making it easier to order tests, the chances of patients completing necessary diagnostics increase, leading to better-informed treatment decisions.
What is the significance of the CRESSO Brands joint venture?
The collaboration known as CRESSO Brands merges the resources of ARCpoint and Any Lab Test Now, forming the largest franchise network for lab tests in the country.
Who stands to benefit from this service?
Both telehealth providers and patients can benefit, as providers have an easier time ordering tests, while patients enjoy greater access to essential testing services.
